Study guide
2.3 Multiple Gestation: Placentation, Chorionicity & Complications
NCC Inpatient Obstetric Nursing RNC-OB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 0: Introduction & How to Use This Guide
0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology
2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions
1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders
3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders
2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications
4 Chapter 3: Antenatal Fetal Assessment & Surveillance
3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation
5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)
4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation
6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support
5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices
7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia
6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia
8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures
7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation
9 Chapter 8: Obstetric Emergencies & Critical Care
8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis
10 Chapter 9: Postpartum Physiology & Immediate Recovery Care
9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety
11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications
10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety
12 Chapter 11: Newborn Care, Transition & Clinical Assessment
11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants
13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management
12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)
14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement
13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines
2.3 Multiple Gestation: Placentation, Chorionicity & Complications
Key Takeaways Explain This Topic AI
Chorionicity (the number of separate placentas) is the primary determinant of pregnancy risk and perinatal morbidity, rather than zygosity (genetic identity).
Ultrasound in the first trimester reliably determines chorionicity: a 'Twin Peak' / Lambda (λ) sign confirms Dichorionic placentation, whereas a 'T-sign' confirms Monochorionic placentation.
Twin-to-Twin Transfusion Syndrome (TTTS) occurs exclusively in Monochorionic gestations due to unbalanced deep arteriovenous anastomoses, characterized by donor oligohydramnios (MVP <2 cm) and recipient polyhydramnios (MVP >8 cm); Quintero staging guides fetoscopic laser photocoagulation.
Monochorionic Monoamniotic (Mo/Mo) twins require elective inpatient fetal surveillance starting at 24 to 28 weeks due to a >95% incidence of umbilical cord entanglement, with planned cesarean delivery at 32 0/7 to 34 0/7 weeks.
ACOG/SMFM delivery timing targets: Uncomplicated Di/Di twins at 38 0/7 to 38 6/7 weeks; uncomplicated Mo/Di twins at 34 0/7 to 37 6/7 weeks (typically 36 0/7 to 37 0/7); Mo/Mo twins at 32 0/7 to 34 0/7 weeks via scheduled cesarean delivery.
Last updated: August 2026
Embryology: Zygosity vs. Chorionicity & Amnionicity
Understanding the anatomical and vascular architecture of multifetal gestations is essential for inpatient obstetric nursing. Chorionicity (the number of chorionic membranes/placentas) is the primary determinant of pregnancy risk, morbidity, and management, rather than zygosity (genetic identity). [ MONOZYGOTIC CLEAVAGE TIMELINE & PLACENTATION ]
- Cleavage Days 0 – 3 Cleavage Days 4 – 8 Cleavage Days 8 – 12 Cleavage >13 Days
- (Morula Stage) (Blastocyst Stage) (Embryonic Disc) (Incomplete Disc)
- │ │ │ │
- ▼ ▼ ▼ ▼
- [ Di / Di ] [ Mo / Di ] [ Mo / Mo ] [ Conjoined ]
- Dichorionic / Diamniotic • Monochorionic / Diamniotic • Monochorionic / Monoamniotic • Shared organs
- 2 Placentas, 2 Amnions • 1 Placenta, 2 Amnions • 1 Placenta, 1 Amnion • Thoracopagus,
- Thick membrane (>2 mm) • Thin membrane (<2 mm) • No dividing membrane Omphalopagus
- Lambda (λ) sign • T-sign • Cord entanglement (>95%) • Very rare (<1:50k)
- ~25–30% of MZ twins • ~70–75% of MZ twins • ~1–2% of MZ twins
- Zygosity & Chorionicity Types
Dizygotic Twins (Fraternal, ~70% of all twins): Fertilization of two distinct ova by two separate sperm. Genetically non-identical. Always Dichorionic / Diamniotic (Di/Di) . Each fetus possesses its own distinct placenta and amniotic sac. (While adjacent placentas may physically fuse, their vascular systems remain completely separate with no communicating anastomoses).
Monozygotic Twins (Identical, ~30% of all twins): A single ovum fertilized by a single sperm that subsequently divides. The timing of cleavage dictates placentation:
Days 0–3 (Morula stage): Cleavage occurs prior to inner cell mass differentiation. Results in Dichorionic / Diamniotic (Di/Di) twins (~25% to 30% of monozygotic gestations). Two separate placentas, two separate chorions, two amniotic sacs.
Days 4–8 (Blastocyst stage): Inner cell mass divides while the trophoblast has already formed. Results in Monochorionic / Diamniotic (Mo/Di) twins (~70% to 75% of monozygotic gestations). Single shared placenta , one chorion, two separate amniotic sacs. Shared placental vascular connections create high risk for hemodynamic complications.
Days 8–12 (Implanted embryonic disc): Division occurs after the amnion has formed. Results in Monochorionic / Monoamniotic (Mo/Mo) twins (~1% to 2% of monozygotic gestations). Single shared placenta, single shared amniotic sac with no dividing membrane . Severe risk of umbilical cord entanglement and knotting.
Day >13: Incomplete embryonic disc division results in Conjoined Twins .
First-Trimester Sonographic Membrane Signs
Lambda (λ) / "Twin Peak" Sign: A triangular wedge of chorionic tissue extending into the base of the inter-twin dividing membrane (>2 mm thickness). Confirms Dichorionic (Di/Di) placentation.
T-Sign: The thin dividing amniotic membrane (<2 mm thickness) attaches directly to the single placental surface at a sharp 90-degree angle without intervening chorionic tissue. Confirms Monochorionic (Mo/Di) placentation.
Monochorionic Vascular Complications
Monochorionic placentas almost universally contain vascular anastomoses connecting the two fetal circulations: superficial arterio-arterial (AA) and veno-venous (VV) connections, and deep, unidirectional arteriovenous (AV) connections within shared placental cotyledons.
1. Twin-to-Twin Transfusion Syndrome (TTTS)
Pathophysiology: Affects 10% to 15% of Mo/Di gestations. Unbalanced net blood flow through deep AV anastomoses from the Donor twin to the Recipient twin.
Donor Twin Manifestations: Severe hypovolemia, decreased renal perfusion, marked oliguria, severe oligohydramnios (Maximum Vertical Pocket [MVP] <2 cm ), "stuck twin" appearance (plastered against the uterine wall), fetal growth restriction, and anemia.
Recipient Twin Manifestations: Severe hypervolemia, increased renal filtration, polyuria, marked polyhydramnios (MVP >8 cm before 20 weeks or >10 cm after 20 weeks), cardiomegaly, systemic hypertension, tricuspid regurgitation, high-output congestive heart failure, and hydrops fetalis.
Quintero Staging System for TTTS
Stage Key Diagnostic Sonographic Features Clinical Prognosis & Action
Stage I Oligohydramnios in donor (MVP <2 cm) AND polyhydramnios in recipient (MVP >8 cm); donor bladder remains visible Conservative surveillance or fetoscopic laser photocoagulation
Stage II Oligo/polyhydramnios sequence AND donor bladder is persistently not visualized over 60 min (anuria) Fetoscopic Laser Photocoagulation (FLOC) indicated
Stage III Stage I/II criteria plus critically abnormal Doppler studies in either twin: absent/reversed end-diastolic velocity (AREDV) in umbilical artery, reversed ductus venosus a-wave, or pulsatile umbilical vein flow Urgent FLOC indicated (high risk of imminent demise)
Stage IV Presence of Hydrops Fetalis (ascites, pleural/pericardial effusion, subcutaneous edema) in either twin (usually recipient) Critical emergency; surgical laser intervention
Stage V Demise of one or both fetuses Co-twin at extreme risk of acute exsanguination/infarction
Definitive Treatment: Fetoscopic Laser Photocoagulation (FLOC / Solomon Technique) between 16 0/7 and 26 0/7 weeks to photocoagulate all communicating vascular anastomoses along the vascular equator, functionally transforming the monochorionic placenta into a dichorionic placenta.
2. Twin Anemia-Polycythemia Sequence (TAPS)
Characterized by slow, chronic feto-fetal transfusion through microscopic AV anastomoses (<1 mm diameter), producing profound hemoglobin discordance (>5 g/dL) without amniotic fluid discordance. Diagnosed by Middle Cerebral Artery Peak Systolic Velocity (MCA-PSV) Doppler: donor twin MCA-PSV >1.5 MoM (severe anemia); recipient twin MCA-PSV <1.0 MoM (severe polycythemia).
3. Twin Reversed Arterial Perfusion (TRAP Sequence / Acardiac Twin)
A rare condition where a normal "pump twin" perfuses an abnormal, non-viable "acardiac twin" retrograde through large AA anastomoses. The pump twin is at high risk of high-output cardiac failure and death (~50%). Managed with radiofrequency ablation (RFA) or bipolar umbilical cord occlusion of the acardiac twin.
4. Monochorionic Monoamniotic (Mo/Mo) Twins
Because both fetuses occupy a single amniotic cavity, umbilical cord entanglement occurs in >95% of cases early in pregnancy. Management requires elective inpatient admission at 24 0/7 to 28 0/7 weeks for daily multi-hour fetal heart rate monitoring, antenatal corticosteroid administration, and planned scheduled cesarean delivery at 32 0/7 to 34 0/7 weeks .
5. Co-Twin Demise in Monochorionic Gestation
If one twin dies in a monochorionic pregnancy, acute maternal-fetal hemodynamics cause sudden, massive reverse exsanguination of the living survivor's blood volume into the lower-resistance vascular bed of the demised twin through patent anastomoses. This causes acute severe hypotension, hypovolemia, ischemic cerebral necrosis (multicystic encephalomalacia), microcephaly, cerebral palsy (~20% to 30%), or acute co-twin demise (~15%). Immediate emergent delivery of the survivor is rarely protective once demise has occurred, as the damage occurs instantaneously at the moment of death.
- Antenatal Surveillance & Delivery Timing Guidelines
- ACOG/SMFM Recommended Delivery Timing for Multifetal Gestations [ RECOMMENDED DELIVERY GESTATIONAL AGES ]
Uncomplicated Di/Di Twins ─────────────────────────► 38 0/7 – 38 6/7 weeks
- Uncomplicated Mo/Di Twins ─────────────────────────► 34 0/7 – 37 6/7 weeks
- (typically 36 0/7 – 37 0/7)
- Uncomplicated Mo/Mo Twins ─────────────────────────► 32 0/7 – 34 0/7 weeks
- (Always via Cesarean Delivery) (Inpatient surveillance at 24–28w)
- Triplet Gestation ─────────────────────────► 35 0/7 – 35 6/7 weeks
- Intrapartum Management of Twin Deliveries
Twin deliveries must take place in an Operating Room (OR) or dedicated surgical delivery suite with full "double-setup" capabilities:
- Two separate neonatal resuscitation teams and two pre-warmed radiant warmers;
- Real-time bedside ultrasound machine ready for immediate use;
- Continuous dual electronic fetal heart rate monitoring;
Immediate access to emergency cesarean delivery and obstetric anesthesia.
Mode of Delivery Criteria
Twin A Vertex / Twin B Vertex: Planned vaginal trial of labor is safe and recommended.
Twin A Vertex / Twin B Non-Vertex (Breech or Transverse): In pregnancies ≥ 32 weeks \ge 32\text{ weeks} ≥ 32 weeks with Twin B estimated weight comparable to Twin A (discordance <20%), a vaginal trial of labor is safe and appropriate when managed by an experienced obstetrician skilled in internal podalic version and breech extraction of Twin B.
Twin A Non-Vertex (Breech or Transverse): Cesarean delivery is recommended for both twins due to the risk of locked twins (Twin A breech chin interlocking with Twin B vertex chin at the pelvic inlet) and cord prolapse.
Specific Intrapartum Nursing Interventions
Continuous Dual EFM: Apply a fetal scalp electrode (FSE) to Twin A once membranes are ruptured, and monitor Twin B with external ultrasound to prevent signal overlap or artifactual tracing of the same fetus.
After Delivery of Twin A: Immediately clamp and label the cord ("Twin A"). Do not administer routine oxytocin bolus until Twin B is delivered. Perform immediate real-time ultrasound to confirm Twin B presentation, lie, and heart rate. Maintain abdominal stabilization of Twin B over the pelvic inlet.
Postpartum Hemorrhage (PPH) Readiness: Marked uterine overdistention dramatically increases the risk of severe postpartum uterine atony. Ensure large-bore IV access, active management of the third stage, high-dose oxytocin infusion, and immediate availability of second-line uterotonics.